CPU-12, a novel synthesized oxazolo[5,4-d]pyrimidine derivative, showed superior anti-angiogenic activity
Keywords: Angiogenesis; Oxazolo[5,4-d]pyrimidine derivatives; Vascular endothelial growth factor receptor (VEGFR); Receptor tyrosine kinase (RTK) inhibitor; The rat aortic ring assay